Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 184 (2) , 32-40
- https://doi.org/10.1067/mob.2001.108328
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal womenBone, 1999
- Effect of estrogens on bone and other systems and hormonal substitute treatmentCurrent Opinion in Rheumatology, 1997
- Hormone replacement therapy in the prevention and treatment of osteoporosisOsteoporosis International, 1997
- Effect of 10 Years' Hormone Replacement Therapy on Bone Mineral Content in Postmenopausal WomenBone, 1996
- Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fracturesJournal of Bone and Mineral Research, 1995
- Management of postmenopausal osteoporosisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1994
- Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assayJournal of Bone and Mineral Research, 1992
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991
- Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapyGynecological Endocrinology, 1987
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976